Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence in Pharmaceuticals
0
Zitationen
3
Autoren
2026
Jahr
Abstract
Artificial Intelligence is continuously changing the landscape of pharmaceutical sciences by solving major issues related to traditional drug discovery and development practices like high cost, long duration and low success rate. This review presents an encompassing overview of Artificial Intelligence applications from drug design and development to delivery in the pharmaceutical pipeline, following a systematic review of recent literature (2020-2025) from major scientific databases followed by thematic analysis and quality assessment. Artificial intelligence techniques (such as machine learning, deep learning, and big data analytics) have significantly improved the drug discovery process because they enable quick screening of enormous molecular datasets, precise prediction of pharmacodynamic interactions, and effective lead optimization. Artificial Intelligence also helps to develop personalized medicine that integrates genomics, proteomics, and clinical data to create custom-tailored therapies for patients. According to the review, creating novel pharmacological indications for already-approved medications can be done quickly and affordably through artificial intelligence-based drug repurposing. The report also suggests how Artificial Intelligence is being implemented in drug delivery systems, pharmacovigilance, clinical trials, healthcare services, etc. to improve patient outcomes and efficiency. Such Artificial Intelligence has a huge potential with great possibilities; however, there are many challenges to its implementation. For instance, bias in data, lack of transparency, regulatory challenges, concerns over data privacy and security, etc. Such challenges highlight the need for strong governance frameworks as well as the need for explainable Artificial Intelligence. Overall, Artificial Intelligence is evolving into an engine of innovation in pharmaceuticals- creating a future of more efficient, accurate, and personalized healthcare solutions. It also illuminates important research gaps and future directions for sustainable integration of these technologies in the healthcare system.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.773 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.682 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.242 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.898 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.